About fdec india

The Foundation for Disease Elimination and Control of India (FDEC India), has been established by the Sun Pharmaceutical Industries Limited, as part of its Corporate Social Responsibility initiative as a not-for-profit company registered under the Section 8 of the Companies Act 2013 (CIN: U85190MH2016NPL286097). The registered office of FDEC is Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (East), Mumbai - 400063, IndiaRead More

Current Programs

Malaria Elimination Demonstration Project (MEDP)

Malaria Elimination Demonstration Project (MEDP) is a first-of-its-kind Public-Private-Partnership between the Indian Council of Medical Research (ICMR), Government of Madhya Pradesh (GoMP), and the Foundation for Disease Elimination and Control of India (FDEC-India), which is established by Sun Pharmaceutical Industries Ltd. as a not-for-profit entity. The unique feature is the focus on public-private partnership where all partners share resources and responsibilities that contribute towards the success of the project. The support we receive from the National Vector Borne Disease Control Program (NVBDCP) and the inter-sectorial participation of local panchayats, civil society and other departments of the government contribute towards the accomplishment of goals of the project. The success of this program will encourage other private sector entities to engage in malaria elimination and similar public health programs directly at the field-level. As we have described in the operational plan (Op plan link), Mandla was chosen because of the experience and knowledge of the National Institute for Research in Tribal Health (NIRTH) in parasitological, entomological, community-based field investigations, drug treatment, and malaria control and elimination and it presents us opportunities to learn lessons in epidemiologic, environmental, demographic, operational, management, and social sciences for state and national malaria elimination programs.Read More

The world with us

The RBM & APLMA Partnership to End Malaria is the largest global platform for coordinated action towards a world free from malaria. It is comprised of over 500 partners-from community health worker groups and researchers developing new tools, to malaria-affected and donor countries, businesses.

Almost half of
the world's
population is at risk

*Ref: WHO fact sheet on malaria

A Child dies
every 2 mins

*Ref: World Malaria Report 2017 by WHO

2000%
Return on Investment

*Ref: Study published in ASTMH

meet the leadership team

  • Dr S Y Quraishi

    A civil servant, Dr Quraishi was the 17th Chief Election Commissioner of India. He revolutionized voter participation in India. For this and other electoral reforms he figured in 100 Most Powerful Indians of 2011 and 2012 by The Indian Express. He has delivered lectures on democracy and elections worldwide. He observed elections in South Africa, Russia, Sri Lanka, Myanmar and most recently in Pakistan, among others. He is on the Board of Advisors of International IDEA (Institute of Democracy and Electoral Assistance) Stockholm. He has been appointed Global Ambassador of Democracy alongside eminent leaders like Kofi Annan. He contributed significantly in the health sector as DG National AIDS Control Organization and Special Secretary Ministry of Health and Family Welfare, dealing with AIDS, TB and Malaria. His book Social Marketing for Social Change (1996) broke new ground in health and development communication.Read More

  • Dr Azadar Khan

    Dr. Azadar Khan currently heads Corporate Relations and Corporate Social Responsibility functions at Sun Pharmaceutical Industries Limited. He is an Industry veteran, carries over 38 years of rich experience in Pharmaceutical Industry encompassing domain of Human Resources, Corporate Relations, Corporate Social Responsibility, Regulatory Affairs, and compliance. He has represented Sun Pharmaceutical Industries Ltd., as well as Indian Pharmaceutical Industries at various forums of the policy makers/stakeholders and provided advisory for ease of business and overall growth of the industry. He has been conferred Honorary Doctoral Awards (Honoris Causa) in the field of Management, by the Governing Council of Confederation of International Accreditation Commission in affiliation with KEISIE International University-KIU, South Korea.Read More

  • Dr. Altaf Lal

    Dr. Lal is Senior Advisor for Global Health and Innovation, Sun Pharmaceuticals Industries Limited, India. He serves on the board of the Roll Back Malaria Partnership Board (RBM), Asia Pacific Leader’s Malaria Alliance (APLMA), and Foundation for Disease Elimination and Control of India (FDEC-India). He also serves as the Chairman of the Board of Sun Pharma Health Care Society. He is serving as the Acting Director of the Malaria Elimination Demonstration Project. He has served as the Director of FDA India Office, Technical Director, Decade of Vaccines Collaboration, Chief Executive Officer, Hilleman Laboratories, U.S. Health Attache and Regional Representative for South Asia at the U.S. Embassy in India, and Chief Malaria Vaccine Section at the Center for Disease Control and Prevention (CDC), Atlanta, GA. He has experience, interest, and knowledge of Discovery, Development, Delivery, and Diplomacy in biomedical sciences and public health. He has over thirty-years’ experience in infectious disease research, vaccines and immunization, biotechnology, global health, product safety, and policy matters. He has strong leadership skills using science-based decision making, strategic thinking, and fostering teamwork approach. Dr. Lal has worked towards building bilateral and multilateral partnerships, which has led to significant growth and collaborations at academic, institutional, industry and government levels. He is recipient of the Life Time Achievement award and Gugnani Oration Medal from the Indian Society of Malaria and other Communicable Disease and India Association of Epidemiologists, Public Health Ambassador Award from the National Centers for Disease Control, and HIV/AIDS Ambassador Award from the Central University of Hyderabad, FDA Commissioner’s Special Citation Award, Unit Citation Award, U.S. Department of Commerce, National Oceanic Atmospheric Administration, National Oceanic Service, James H. Nakano Citation, National Center for Infectious Disease (NICD), CDC, Outstanding Scientific Contribution to Public Health Award. Dr. Lal has published over 220 papers.Read More

  • Dr Nilima Kshirsagar

    Dr Kshirsagar is currently National Chair of Clinical Pharmacology, ICMR, Govt. of India, New Delhi, Member Investigational New Drugs (IND) committee, DTAB (Drug technical Advisory Board), Chairman core training Panel PvPI Govt. of India. Chairperson, DSMC Bedaquiline Conditional Access Program for tuberculosis, Govt. of India Chairperson, Subcommittee of Drug Technical Advisory Committee for fixed dose combination, Govt. of India Member Board, Foundation for Diseases Elimination and control, Sun ICMR collaboration Fellow of National Academy of Sciences, India. Fellow of National Academy of Medical Sciences, India. She is also the Secretary General of Clinical Pharmacology division IUPHAR.Read More

  • Prof. Dr. Y K Gupta

    He is the Principal Adviser (Projects),THSTI – Deptt. of Biotechnology, GOI and the Former Dean ( Academics), and Head, Department of Pharmacology, AIIMS, New Delhi where he established Clinical Pharmacology. Dr. Gupta is the Chairman of Task Force on Nano Biotechnology. He served as Chairman of National GLP Technical Committee of DST, member of the Scientific Body of Indian Pharmacopoeia (IP) and Chairman of Expert Committee on Clinical Medicine and Pharmacology of IP. He is also the Chairman / Member of Institutional ethics committees of reputed institutions eg IIT Delhi , ILBS, Medanta, AIIMS DelhiRead More

  • Prof A P Dash

    Credited with Ph. D. and D. Sc. degrees in Zoology, Professor Dash has significantly contributed in the field malaria and other vector borne neglected tropical diseases affecting the poorest of the poor. He served as Director of five different national research institutes including the National Institute for Malaria Research and National Institute of Research in Tribal Health. He was also the Regional Adviser at the South East Asia Regional Office of the World Health Organization. Currently he is working as the Vice Chancellor of the Central University of Tamil Nadu.Read More

  • Dr. K K Aggarwal

    Dr Aggarwal is the immediate past national president of IMA. He is the recipient of four National Awards - Padma Shri, Vishwa Hindi Samman, Dr B C Roy National Award and National Science Communication Award and one State Delhi Hindi Sahitya Samellan - Sahitya Shree Award 2007 (Doctor and Philosopher of Indian Culture). He is the Limca Book of Record Holder in CPR 10, a gold medallist, a TEDx Speaker & the recipient of FICCI Health Care Personality of the Year Award 2016. He is also the President (Elect) Confederation of Medical Associations of Asia and Oceania, President Heart Care Foundation of India, Group Editor in Chief IJCP Group, IMA UNESCO Chair in Bioethics, Former Ethics Committee Member Medical Council of India and Former Chairman Ethics Committee Delhi Medical Council.Read More

news & resources